Jiangsu Bioperfectus Technologies Co., Ltd.

Today, we spotlight the remarkable journey of BioPerfectus's global footprint, a testament to our significant growth and expansion. Our unwavering commitment to global health has been the guiding force, reinforcing our mission, "BioPerfectus, for a healthier future". Our international strategy has been pivotal in our success, with the establishment of subsidiaries in strategic locations such as the United States, Hong Kong, and the United Kingdom. This strategic expansion has enabled us to cater to various markets and meet our customers' diverse needs more effectively. In times of global health crises, BioPerfectus has played a crucial role, contributing significantly to the fight against major pandemics such as COVID-19, Monkeypox, and Ebola. Our unwavering commitment and demonstrated responsibility during these critical periods are sources of immense pride. The dedicated efforts of our partners and employees have significantly contributed to our success story. Their experiences and collaborations have fostered strong relationships and driven the mutual growth that is at the heart of BioPerfectus's global footprint. As we acknowledge our achievements, we also envision a future brimming with opportunities. Our CEO, Dr. Guoqiang Wang, provides a clear vision for BioPerfectus's future and our ongoing development plans. His inspiring words motivate our team and partners to rise above challenges and achieve more. In recognition of this significant journey, we express our deepest gratitude to our dedicated team and partners. Your commitment and passion have turned our shared vision into reality, and for that, we say, "Thank you!" We move forward with an unwavering commitment to our mission, ready to seize the opportunities of tomorrow. As we continue to acknowledge our past successes and eagerly anticipate a future full of growth, innovation, and contribution to global health, we affirm our unity as BioPerfectus. Together, let's forge ahead towards a healthier future!

SHANGHAI, CHINA, April 27, 2023Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as BioPerfectus) announces the CE marking of one new product:Herpes Simplex Virus Type I/II Real Time PCR Kit. Combined with ourAutomated Nucleic Acid Extraction WorkstationandReal Time PCR System, we could provide a STD total PCR solution for the early detection of sexually transmitted diseases which affect many people. Herpes simplex virus (HSV), a common infection that can cause painful blisters or ulcers, is widespread among humans globally. It primarily spreads by skin-to-skin contact. The infection is lifelong and characterized by periodic reactivations at the infection site. Globally, more than 500 million people have genital herpes simplex virus infection. An estimated 3.7 billion people under age 50 (67%) have herpes simplex virus type 1 (HSV-1) infection, the main cause of oral herpes and 491 million people aged 1549 (13%) have herpes simplex virus type 2 (HSV-2) infection, the main cause of genital herpes. The overall rate of neonatal herpes was estimated to be about ten cases per 100 000 live births, equivalent to a best estimate of 14 000 cases annually roughly (4000 for HSV-1; 10 000 for HSV-2). Fig. Map of regional estimates of the number and prevalence of herpes simplex virus type 2 infections in females and males, 2016 In order to better deal with this global burden, the World Health Assembly adopted the Global Health Sector Strategy on Sexually Transmitted Infections, 20162021, which aims to end sexually transmitted infections as a public health concern by 2030, focusing on vastly scale up primary prevention and increase access to screening for sexually transmitted infections. As for herpes simplex virus, which is highly contagious and can be transmitted via any type of physical contact, early and accurate detection is needed to prevent the transmission. Whats worse, genital herpes can cause painful genital sores and can be severe in people with suppressed immune systems if left without treatment. As a pioneer in molecular diagnostics, BioPerfectus remains dedicated to developing new diagnostic solutions, working diligently to offer a comprehensive range of STI panels. By offering a comprehensive STD diagnostic solution, BioPerfectus is committed to aiding in the early-stage screening and diagnosis of various sexually transmitted infections, ensuring accurate detection to prevent severe outcomes. Reference: -https://www.cdc.gov/std/herpes/stdfact-herpes.htm -https://www.who.int/news-room/fact-sheets/detail/herpes-simplex-virus -James, Charlotte et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016.Bulletin of the World Health Organizationvol. 98,5 (2020): 315-329. doi:10.2471/BLT.19.237149 -Looker, Katharine J et al. First estimates of the global and regional incidence of neonatal herpes infection.The Lancet. Global healthvol. 5,3 (2017): e300-e309. doi:10.1016/S2214-109X(16)30362-X

SHANGHAI, CHINA, April 26th, 2023Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as "BioPerfectus") is proud to announce the release of three new products: Nucleic Acid Extraction System SSNP-A6 (FDA-listed,CE-IVDR), Nucleic Acid Extraction Rapid Kit 96T (Magnetic Bead Method) (CE-IVDR) and Nucleic Acid Extraction and Purification Rapid Kit 96T (CE-IVDR ). Designed for high efficiency and continuous high throughput, these products offer a rapid and automated solution for the extraction of nucleic acids. SSNP-A6 is an in vitro diagnostic medical device, which integrates cutting-edge mechanical, electronic and software technologies. Compatible with Nucleic Acid Extraction Rapid Kit 96T (Magnetic Bead Method), SSNP-A6 enables automated extraction of nucleic acids from samples such as nasopharyngeal swab, pharyngeal swab, nasal swab, serum, plasma, urine, cervical swab, urethral swab, etc. Meanwhile, SSNP-A6 can extract nucleic acids from 96 samples simultaneously to meet the requirement for high throughput. Nucleic Acid Extraction and Purification Rapid Kit 96T is designed to work with the KingFisher Flex, KingFisher Apex, and other fully automated nucleic acid extraction systems produced by Thermo Fisher Scientific. It can efficiently extract from samples such as nasopharyngeal swab, pharyngeal swab, nasal swab, serum, plasma, urine, cervical swab, urethral swab, etc. As a company dedicated to addressing the health challenges faced by humanity, BioPerfectus continues to embrace innovation and pursue excellence in the field of molecular diagnostics.